Q3 FY2026 · ended Sep 30, 2026 · Revenue $4.43B, +8.0% YoY · Filed Oct 27, 2026
Iqvia Holdings Inc. (IQV) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $4.4 billion and net income of $350.0 million. Free cash flow was $667.0 million. As of Sep 30, 2026 it held $2.4 billion in cash and investments and $16.3 billion in total debt.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- IQV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1478242
- Former names
- Quintiles IMS Holdings, Inc. (until Nov 3, 2017); Quintiles Transnational Holdings Inc. (until Sep 22, 2016)
Other Services-Commercial Physical & Biological Research companies
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $4.4B | $4.4B | $4.2B | $4.4B | $4.1B |
| Operating income | $572.0M | $506.0M | $514.0M | $627.0M | $553.0M |
| Net income | $350.0M | $256.0M | $274.0M | $514.0M | $331.0M |
| Diluted EPS | $2.10 | $1.53 | $1.61 | $2.99 | $1.93 |
| Operating cash flow | $825.0M | $558.0M | $618.0M | $735.0M | $908.0M |
| Free cash flow | $667.0M | $360.0M | $491.0M | $561.0M | $772.0M |
| Total assets | $30.5B | $29.9B | $29.7B | $29.9B | $28.7B |
| Total liabilities | $23.7B | $23.6B | $23.3B | $23.3B | $22.4B |
| Stockholders' equity | $6.7B | $6.2B | $6.2B | $6.5B | $6.2B |
| Cash and investments | $2.4B | $2.1B | $2.1B | $2.1B | $2.0B |
| Total debt | $16.3B | $16.2B | $16.1B | $16.3B | $15.2B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 27, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Jul 28, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2026 | Jul 28, 2026 |
All 1000 Iqvia Holdings Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.